Your browser doesn't support javascript.
loading
Size-Selective Phagocytic Clearance of Fibrillar α-Synuclein through Conformational Activation of Complement Receptor 4.
Juul-Madsen, Kristian; Qvist, Per; Bendtsen, Kirstine L; Langkilde, Annette E; Vestergaard, Bente; Howard, Kenneth A; Dehesa-Etxebeste, Martxel; Paludan, Søren R; Andersen, Gregers Rom; Jensen, Poul Henning; Otzen, Daniel E; Romero-Ramos, Marina; Vorup-Jensen, Thomas.
Afiliação
  • Juul-Madsen K; Biophysical Immunology Laboratory, Aarhus University, DK-8000 Aarhus C, Denmark.
  • Qvist P; Department of Biomedicine, Aarhus University, DK-8000 Aarhus C, Denmark.
  • Bendtsen KL; Department of Biomedicine, Aarhus University, DK-8000 Aarhus C, Denmark.
  • Langkilde AE; iPSYCH, The Lundbeck Foundation Initiative for Integrative Psychiatric Research, Aarhus University, DK-8000 Aarhus C, Denmark.
  • Vestergaard B; iSEQ, Centre for Integrative Sequencing, Department of Biomedicine, Aarhus University, DK-8000 Aarhus C, Denmark.
  • Howard KA; Department of Drug Design and Pharmacology, University of Copenhagen, DK-2100 Copenhagen Ø, Denmark.
  • Dehesa-Etxebeste M; Department of Drug Design and Pharmacology, University of Copenhagen, DK-2100 Copenhagen Ø, Denmark.
  • Paludan SR; Department of Drug Design and Pharmacology, University of Copenhagen, DK-2100 Copenhagen Ø, Denmark.
  • Andersen GR; Interdisciplinary Nanoscience Center, Aarhus University, DK-8000 Aarhus C, Denmark.
  • Jensen PH; Neuroscience Area, Biodonostia Research Institute, 20014 Donostia, San Sebastian, Spain.
  • Otzen DE; CIBERNED, Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Romero-Ramos M; Department of Biomedicine, Aarhus University, DK-8000 Aarhus C, Denmark.
  • Vorup-Jensen T; Department of Molecular Biology and Genetics, Aarhus University, DK-8000 Aarhus C, Denmark.
J Immunol ; 204(5): 1345-1361, 2020 03 01.
Article em En | MEDLINE | ID: mdl-31969389
ABSTRACT
Aggregation of α-synuclein (αSN) is an important histological feature of Parkinson disease. Recent studies showed that the release of misfolded αSN from human and rodent neurons is relevant to the progression and spread of αSN pathology. Little is known, however, about the mechanisms responsible for clearance of extracellular αSN. This study found that human complement receptor (CR) 4 selectively bound fibrillar αSN, but not monomeric species. αSN is an abundant protein in the CNS, which potentially could overwhelm clearance of cytotoxic αSN species. The selectivity of CR4 toward binding fibrillar αSN consequently adds an important αSN receptor function for maintenance of brain homeostasis. Based on the recently solved structures of αSN fibrils and the known ligand preference of CR4, we hypothesize that the parallel monomer stacking in fibrillar αSN creates a known danger-associated molecular pattern of stretches of anionic side chains strongly bound by CR4. Conformational change in the receptor regulated tightly clearance of fibrillar αSN by human monocytes. The induced change coupled concomitantly with phagolysosome formation. Data mining of the brain transcriptome in Parkinson disease patients supported CR4 as an active αSN clearance mechanism in this disease. Our results associate an important part of the innate immune system, namely complement receptors, with the central molecular mechanisms of CNS protein aggregation in neurodegenerative disorders.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Fagossomos / Integrina alfaXbeta2 / Alfa-Sinucleína / Agregação Patológica de Proteínas / Macrófagos Limite: Humans Idioma: En Revista: J Immunol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Dinamarca

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Fagossomos / Integrina alfaXbeta2 / Alfa-Sinucleína / Agregação Patológica de Proteínas / Macrófagos Limite: Humans Idioma: En Revista: J Immunol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Dinamarca